Indication
COVID-19 post-exposure prevention
COVID-19 post-exposure prevention refers to a prophylactic clinical strategy administered to asymptomatic individuals following confirmed or suspected close contact with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Read more about COVID-19 post-exposure prevention
1 drugs 1 manufacturers
Drugs that treat it
Common COVID-19 post-exposure prevention therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCOVID-19 post-exposure prevention refers to a prophylactic clinical strategy administered to asymptomatic individuals following confirmed or suspected close contact with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
This intervention primarily targets the respiratory epithelium and systemic circulation in exposed populations, particularly individuals at elevated risk for severe disease progression due to advanced age, underlying medical comorbidities, or immunocompromised status.
Pathophysiologically, it aims to intercept and suppress viral attachment, cellular entry, or early viral replication before SARS-CoV-2 establishes systemic dissemination and triggers acute inflammatory cascades, thereby preventing symptomatic coronavirus disease 2019 and associated lower respiratory tract complications.
- nih.gov
COVID-19 post-exposure prevention refers to a prophylactic clinical strategy administered to asymptomatic individuals following confirmed or suspected close contact with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- nih.gov
COVID-19 post-exposure prevention refers to a prophylactic clinical strategy administered to asymptomatic individuals following confirmed or suspected close contact with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- fda.gov
This intervention primarily targets the respiratory epithelium and systemic circulation in exposed populations, particularly individuals at elevated risk for severe disease progression due to advanced age, underlying medical comorbidities, or immunocompromised status
- cdc.gov
This intervention primarily targets the respiratory epithelium and systemic circulation in exposed populations, particularly individuals at elevated risk for severe disease progression due to advanced age, underlying medical comorbidities, or immunocompromised status
- nih.gov
Pathophysiologically, it aims to intercept and suppress viral attachment, cellular entry, or early viral replication before SARS-CoV-2 establishes systemic dissemination and triggers acute inflammatory cascades, thereby preventing symptomatic coronavirus disease 2019 and associated lower respiratory tract complications
- nih.gov
Pathophysiologically, it aims to intercept and suppress viral attachment, cellular entry, or early viral replication before SARS-CoV-2 establishes systemic dissemination and triggers acute inflammatory cascades, thereby preventing symptomatic coronavirus disease 2019 and associated lower respiratory tract complications
Personalize your experience
Follow COVID-19 post-exposure prevention and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.